APO Research
Talk to an analyst

APO RESEARCH · REPORT

Levonorgestrel API

Levonorgestrel is a hormonal medication which is used in a number of birth control methods.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Levonorgestrel is a hormonal medication which is used in a number of birth control methods.

Selected research

Industry Growth & Trends

Global Levonorgestrel API Industry Growth and Trends Forecast to 2032

28 December 202598 pages

Choose your research edition.

Industry ResearchLevonorgestrel API Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Levonorgestrel API Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Levonorgestrel API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Levonorgestrel API Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Levonorgestrel API Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Levonorgestrel is a hormonal medication which is used in a number of birth control methods.

By type, the Global Levonorgestrel API market share is the highest in the short-acting contraceptive API, about 67.17%. The most proportion of the Global Levonorgestrel API market share is used for Levonorgestrel Tablet and the proportion is about 52.74% in 2020.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Levonorgestrel API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Levonorgestrel API market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Levonorgestrel API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Levonorgestrel API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Levonorgestrel API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Levonorgestrel API Market by Company

Bayer HealthCare

Qinhuangdao Zizhu Pharmaceutical

Yangzhou Pharmaceutical

Lupin

Hubei Gedian Humanwell

Sterling Spa

Formos

Huazhong Pharm

ASG Biochem

Levonorgestrel API Segment by Type

Short-Acting Contraceptive API

Long-Acting Contraceptive API

Levonorgestrel API Segment by Application

Levonorgestrel Tablet

Mixture Products

Hormone-releasing IUD

Levonorgestrel API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Levonorgestrel API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Levonorgestrel API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Levonorgestrel API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Levonorgestrel API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Levonorgestrel API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Short-Acting Contraceptive API Table 2. Major Company of Long-Acting Contraceptive API Table 3. Global Levonorgestrel API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Levonorgestrel API Sales by Type (2021-2026) & (Kg) Table 5. Global Levonorgestrel API Sales Market Share in Volume by Type (2021-2026) Table 6. Global Levonorgestrel API Sales by Type (2021-2026) & (US$ Million) Table 7. Global Levonorgestrel API Sales Market Share in Value by Type (2021-2026) Table 8. Global Levonorgestrel API Price by Type (2021-2026) & (USD/KG) Table 9. Global Levonorgestrel API Sales by Type (2027-2032) & (Kg) Table 10. Global Levonorgestrel API Sales Market Share in Volume by Type (2027-2032) Table 11. Global Levonorgestrel API Sales by Type (2027-2032) & (US$ Million) Table 12. Global Levonorgestrel API Sales Market Share in Value by Type (2027-2032) Table 13. Global Levonorgestrel API Price by Type (2027-2032) & (USD/KG) Table 14. North America Levonorgestrel API Sales by Type (2021-2026) & (Kg) Table 15. North America Levonorgestrel API Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Levonorgestrel API Sales by Type (2021-2026) & (Kg) Table 17. Europe Levonorgestrel API Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Levonorgestrel API Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Levonorgestrel API Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Levonorgestrel API Sales by Type (2021-2026) & (Kg) Table 21. Latin America Levonorgestrel API Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Levonorgestrel API Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Levonorgestrel API Sales by Type (2021-2026) & (US$ Million) Table 24. Levonorgestrel API Industry Trends Table 25. Levonorgestrel API Industry Drivers Table 26. Levonorgestrel API Industry Opportunities and Challenges Table 27. Levonorgestrel API Industry Restraints Table 28. Global Levonorgestrel API Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Levonorgestrel API Revenue Market Share by Company (2021-2026) Table 30. Global Levonorgestrel API Sales by Company (2021-2026) & (Kg) Table 31. Global Levonorgestrel API Sales Share by Company (2021-2026) Table 32. Global Levonorgestrel API Market Price by Company (2021-2026) & (USD/KG) Table 33. Global Levonorgestrel API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Levonorgestrel API Major Company Production Sites and Headquarters Table 35. Global Levonorgestrel API Company, Product Type & Application Table 36. Global Levonorgestrel API Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Levonorgestrel API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Levonorgestrel API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Levonorgestrel API Sales by Region (2021-2026) & (Kg) Table 41. Global Levonorgestrel API Sales Market Share in Volume by Region (2021-2026) Table 42. Global Levonorgestrel API Sales by Region (2021-2026) & (US$ Million) Table 43. Global Levonorgestrel API Sales Market Share in Value by Region (2021-2026) Table 44. Global Levonorgestrel API Sales (Kg), Value (US$ Million), Price (USD/KG) and Gross Margin (2021-2026) Table 45. Global Levonorgestrel API Sales by Region (2027-2032) & (Kg) Table 46. Global Levonorgestrel API Sales Market Share in Volume by Region (2027-2032) Table 47. Global Levonorgestrel API Sales by Region (2027-2032) & (US$ Million) Table 48. Global Levonorgestrel API Sales Market Share in Value by Region (2027-2032) Table 49. Global Levonorgestrel API Sales (Kg), Value (US$ Million), Price (USD/KG) and Gross Margin (2027-2032) Table 50. Global Levonorgestrel API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Levonorgestrel API Sales by Application (2021-2026) & (Kg) Table 52. Global Levonorgestrel API Sales Market Share in Volume by Application (2021-2026) Table 53. Global Levonorgestrel API Sales by Application (2021-2026) & (US$ Million) Table 54. Global Levonorgestrel API Sales Market Share in Value by Application (2021-2026) Table 55. Global Levonorgestrel API Price by Application (2021-2026) & (USD/KG) Table 56. Global Levonorgestrel API Sales by Application (2027-2032) & (Kg) Table 57. Global Levonorgestrel API Sales Market Share in Volume by Application (2027-2032) Table 58. Global Levonorgestrel API Sales by Application (2027-2032) & (US$ Million) Table 59. Global Levonorgestrel API Sales Market Share in Value by Application (2027-2032) Table 60. Global Levonorgestrel API Price by Application (2027-2032) & (USD/KG) Table 61. North America Levonorgestrel API Sales by Application (2021-2026) & (Kg) Table 62. North America Levonorgestrel API Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Levonorgestrel API Sales by Application (2021-2026) & (Kg) Table 64. Europe Levonorgestrel API Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Levonorgestrel API Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Levonorgestrel API Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Levonorgestrel API Sales by Application (2021-2026) & (Kg) Table 68. Latin America Levonorgestrel API Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Levonorgestrel API Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Levonorgestrel API Sales by Application (2021-2026) & (US$ Million) Table 71. Bayer HealthCare Company Information Table 72. Bayer HealthCare Business Overview Table 73. Bayer HealthCare Levonorgestrel API Sales (Kg), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2021-2026) Table 74. Bayer HealthCare Levonorgestrel API Product Portfolio Table 75. Bayer HealthCare Recent Development Table 76. Qinhuangdao Zizhu Pharmaceutical Company Information Table 77. Qinhuangdao Zizhu Pharmaceutical Business Overview Table 78. Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales (Kg), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2021-2026) Table 79. Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Product Portfolio Table 80. Qinhuangdao Zizhu Pharmaceutical Recent Development Table 81. Yangzhou Pharmaceutical Company Information Table 82. Yangzhou Pharmaceutical Business Overview Table 83. Yangzhou Pharmaceutical Levonorgestrel API Sales (Kg), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2021-2026) Table 84. Yangzhou Pharmaceutical Levonorgestrel API Product Portfolio Table 85. Yangzhou Pharmaceutical Recent Development Table 86. Lupin Company Information Table 87. Lupin Business Overview Table 88. Lupin Levonorgestrel API Sales (Kg), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2021-2026) Table 89. Lupin Levonorgestrel API Product Portfolio Table 90. Lupin Recent Development Table 91. Hubei Gedian Humanwell Company Information Table 92. Hubei Gedian Humanwell Business Overview Table 93. Hubei Gedian Humanwell Levonorgestrel API Sales (Kg), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2021-2026) Table 94. Hubei Gedian Humanwell Levonorgestrel API Product Portfolio Table 95. Hubei Gedian Humanwell Recent Development Table 96. Sterling Spa Company Information Table 97. Sterling Spa Business Overview Table 98. Sterling Spa Levonorgestrel API Sales (Kg), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2021-2026) Table 99. Sterling Spa Levonorgestrel API Product Portfolio Table 100. Sterling Spa Recent Development Table 101. Formos Company Information Table 102. Formos Business Overview Table 103. Formos Levonorgestrel API Sales (Kg), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2021-2026) Table 104. Formos Levonorgestrel API Product Portfolio Table 105. Formos Recent Development Table 106. Huazhong Pharm Company Information Table 107. Huazhong Pharm Business Overview Table 108. Huazhong Pharm Levonorgestrel API Sales (Kg), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2021-2026) Table 109. Huazhong Pharm Levonorgestrel API Product Portfolio Table 110. Huazhong Pharm Recent Development Table 111. ASG Biochem Company Information Table 112. ASG Biochem Business Overview Table 113. ASG Biochem Levonorgestrel API Sales (Kg), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2021-2026) Table 114. ASG Biochem Levonorgestrel API Product Portfolio Table 115. ASG Biochem Recent Development Table 116. North America Levonorgestrel API Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 117. North America Levonorgestrel API Sales by Country (2021-2026) & (Kg) Table 118. North America Levonorgestrel API Sales Market Share by Country (2021-2026) Table 119. North America Levonorgestrel API Sales Forecast by Country (2027-2032) & (Kg) Table 120. North America Levonorgestrel API Sales Market Share Forecast by Country (2027-2032) Table 121. North America Levonorgestrel API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Levonorgestrel API Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Levonorgestrel API Market Share by Country (2021-2026) Table 124. North America Levonorgestrel API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Levonorgestrel API Market Share Forecast by Country (2027-2032) Table 126. Europe Levonorgestrel API Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 127. Europe Levonorgestrel API Sales by Country (2021-2026) & (Kg) Table 128. Europe Levonorgestrel API Sales Market Share by Country (2021-2026) Table 129. Europe Levonorgestrel API Sales Forecast by Country (2027-2032) & (Kg) Table 130. Europe Levonorgestrel API Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Levonorgestrel API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Levonorgestrel API Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Levonorgestrel API Market Share by Country (2021-2026) Table 134. Europe Levonorgestrel API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Levonorgestrel API Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Levonorgestrel API Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Levonorgestrel API Sales by Country (2021-2026) & (Kg) Table 138. Asia-Pacific Levonorgestrel API Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Levonorgestrel API Sales Forecast by Country (2027-2032) & (Kg) Table 140. Asia-Pacific Levonorgestrel API Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Levonorgestrel API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Levonorgestrel API Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Levonorgestrel API Market Share by Country (2021-2026) Table 144. Asia-Pacific Levonorgestrel API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Levonorgestrel API Market Share Forecast by Country (2027-2032) Table 146. Latin America Levonorgestrel API Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 147. Latin America Levonorgestrel API Sales by Country (2021-2026) & (Kg) Table 148. Latin America Levonorgestrel API Sales Market Share by Country (2021-2026) Table 149. Latin America Levonorgestrel API Sales Forecast by Country (2027-2032) & (Kg) Table 150. Latin America Levonorgestrel API Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Levonorgestrel API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Levonorgestrel API Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Levonorgestrel API Market Share by Country (2021-2026) Table 154. Latin America Levonorgestrel API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Levonorgestrel API Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Levonorgestrel API Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Levonorgestrel API Sales by Country (2021-2026) & (Kg) Table 158. Middle East and Africa Levonorgestrel API Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Levonorgestrel API Sales Forecast by Country (2027-2032) & (Kg) Table 160. Middle East and Africa Levonorgestrel API Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Levonorgestrel API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Levonorgestrel API Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Levonorgestrel API Market Share by Country (2021-2026) Table 164. Middle East and Africa Levonorgestrel API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Levonorgestrel API Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Levonorgestrel API Distributors List Table 169. Levonorgestrel API Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Levonorgestrel API Image Figure 2. Global Levonorgestrel API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Levonorgestrel API Market Size (2021-2032) & (US$ Million) Figure 4. Global Levonorgestrel API Sales (2021-2032) & (Kg) Figure 5. Short-Acting Contraceptive API Image Figure 6. Global Short-Acting Contraceptive API Sales YoY Growth (2021-2032) & (Kg) Figure 7. Long-Acting Contraceptive API Image Figure 8. Global Long-Acting Contraceptive API Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Levonorgestrel API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Levonorgestrel API Market Share by Type 2025 VS 2032 Figure 11. North America Levonorgestrel API Sales Market Share in Volume by Type in 2025 Figure 12. North America Levonorgestrel API Sales Market Share in Value by Type in 2025 Figure 13. Europe Levonorgestrel API Sales Market Share in Volume by Type in 2025 Figure 14. Europe Levonorgestrel API Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Levonorgestrel API Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Levonorgestrel API Sales Market Share in Value by Type in 2025 Figure 17. Latin America Levonorgestrel API Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Levonorgestrel API Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Levonorgestrel API Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Levonorgestrel API Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Levonorgestrel API Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Levonorgestrel Tablet Image Figure 24. Global Levonorgestrel Tablet Sales YoY Growth (2021-2032) & (Kg) Figure 25. Mixture Products Image Figure 26. Global Mixture Products Sales YoY Growth (2021-2032) & (Kg) Figure 27. Hormone-releasing IUD Image Figure 28. Global Hormone-releasing IUD Sales YoY Growth (2021-2032) & (Kg) Figure 29. Global Levonorgestrel API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Levonorgestrel API Market Share by Application 2025 VS 2032 Figure 31. North America Levonorgestrel API Sales Market Share in Volume by Application in 2025 Figure 32. North America Levonorgestrel API Sales Market Share in Value by Application in 2025 Figure 33. Europe Levonorgestrel API Sales Market Share in Volume by Application in 2025 Figure 34. Europe Levonorgestrel API Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Levonorgestrel API Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Levonorgestrel API Sales Market Share in Value by Application in 2025 Figure 37. Latin America Levonorgestrel API Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Levonorgestrel API Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Levonorgestrel API Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Levonorgestrel API Sales Market Share in Value by Application in 2025 Figure 41. North America Levonorgestrel API Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 42. North America Levonorgestrel API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Levonorgestrel API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Levonorgestrel API Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Levonorgestrel API Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 46. Europe Levonorgestrel API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Levonorgestrel API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Levonorgestrel API Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Levonorgestrel API Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 50. Asia-Pacific Levonorgestrel API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Levonorgestrel API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Levonorgestrel API Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Levonorgestrel API Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 54. Latin America Levonorgestrel API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Levonorgestrel API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Levonorgestrel API Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Levonorgestrel API Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 58. Middle East and Africa Levonorgestrel API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Levonorgestrel API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Levonorgestrel API Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Levonorgestrel API Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Levonorgestrel API Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Short-Acting Contraceptive API
  • Long-Acting Contraceptive API
Applications
  • Levonorgestrel Tablet
  • Mixture Products
  • Hormone-releasing IUD
Companies covered
  • Bayer HealthCare
  • Qinhuangdao Zizhu Pharmaceutical
  • Yangzhou Pharmaceutical
  • Lupin
  • Hubei Gedian Humanwell
  • Sterling Spa
  • Formos
  • Huazhong Pharm
  • ASG Biochem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Levonorgestrel API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Levonorgestrel API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Levonorgestrel API Market by Type
  6. 1.3.1 Short-Acting Contraceptive API
  7. 1.3.2 Long-Acting Contraceptive API
  8. 1.4 Global Levonorgestrel API Market Size by Type
  9. 1.4.1 Global Levonorgestrel API Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Levonorgestrel API Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Levonorgestrel API Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Levonorgestrel API Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Levonorgestrel API Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Levonorgestrel API Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Levonorgestrel API Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Levonorgestrel API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Levonorgestrel API Industry Trends
  2. 2.2 Levonorgestrel API Industry Drivers
  3. 2.3 Levonorgestrel API Industry Opportunities and Challenges
  4. 2.4 Levonorgestrel API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Levonorgestrel API Revenue (2021-2026)
  2. 3.2 Global Top Players by Levonorgestrel API Sales (2021-2026)
  3. 3.3 Global Top Players by Levonorgestrel API Price (2021-2026)
  4. 3.4 Global Levonorgestrel API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Levonorgestrel API Major Company Production Sites & Headquarters
  6. 3.6 Global Levonorgestrel API Company, Product Type & Application
  7. 3.7 Global Levonorgestrel API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Levonorgestrel API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Levonorgestrel API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Levonorgestrel API Tier 1, Tier 2, and Tier 3
4 Levonorgestrel API Regional Status and Outlook
  1. 4.1 Global Levonorgestrel API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Levonorgestrel API Historic Market Size by Region
  3. 4.2.1 Global Levonorgestrel API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Levonorgestrel API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Levonorgestrel API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Levonorgestrel API Forecasted Market Size by Region
  7. 4.3.1 Global Levonorgestrel API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Levonorgestrel API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Levonorgestrel API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Levonorgestrel API by Application
  1. 5.1 Levonorgestrel API Market by Application
  2. 5.1.1 Levonorgestrel Tablet
  3. 5.1.2 Mixture Products
  4. 5.1.3 Hormone-releasing IUD
  5. 5.2 Global Levonorgestrel API Market Size by Application
  6. 5.2.1 Global Levonorgestrel API Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Levonorgestrel API Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Levonorgestrel API Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Levonorgestrel API Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Levonorgestrel API Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Levonorgestrel API Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Levonorgestrel API Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Levonorgestrel API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bayer HealthCare
  2. 6.1.1 Bayer HealthCare Company Information
  3. 6.1.2 Bayer HealthCare Business Overview
  4. 6.1.3 Bayer HealthCare Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bayer HealthCare Levonorgestrel API Product Portfolio
  6. 6.1.5 Bayer HealthCare Recent Developments
  7. 6.2 Qinhuangdao Zizhu Pharmaceutical
  8. 6.2.1 Qinhuangdao Zizhu Pharmaceutical Company Information
  9. 6.2.2 Qinhuangdao Zizhu Pharmaceutical Business Overview
  10. 6.2.3 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Product Portfolio
  12. 6.2.5 Qinhuangdao Zizhu Pharmaceutical Recent Developments
  13. 6.3 Yangzhou Pharmaceutical
  14. 6.3.1 Yangzhou Pharmaceutical Company Information
  15. 6.3.2 Yangzhou Pharmaceutical Business Overview
  16. 6.3.3 Yangzhou Pharmaceutical Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Yangzhou Pharmaceutical Levonorgestrel API Product Portfolio
  18. 6.3.5 Yangzhou Pharmaceutical Recent Developments
  19. 6.4 Lupin
  20. 6.4.1 Lupin Company Information
  21. 6.4.2 Lupin Business Overview
  22. 6.4.3 Lupin Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Lupin Levonorgestrel API Product Portfolio
  24. 6.4.5 Lupin Recent Developments
  25. 6.5 Hubei Gedian Humanwell
  26. 6.5.1 Hubei Gedian Humanwell Company Information
  27. 6.5.2 Hubei Gedian Humanwell Business Overview
  28. 6.5.3 Hubei Gedian Humanwell Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hubei Gedian Humanwell Levonorgestrel API Product Portfolio
  30. 6.5.5 Hubei Gedian Humanwell Recent Developments
  31. 6.6 Sterling Spa
  32. 6.6.1 Sterling Spa Company Information
  33. 6.6.2 Sterling Spa Business Overview
  34. 6.6.3 Sterling Spa Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sterling Spa Levonorgestrel API Product Portfolio
  36. 6.6.5 Sterling Spa Recent Developments
  37. 6.7 Formos
  38. 6.7.1 Formos Company Information
  39. 6.7.2 Formos Business Overview
  40. 6.7.3 Formos Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Formos Levonorgestrel API Product Portfolio
  42. 6.7.5 Formos Recent Developments
  43. 6.8 Huazhong Pharm
  44. 6.8.1 Huazhong Pharm Company Information
  45. 6.8.2 Huazhong Pharm Business Overview
  46. 6.8.3 Huazhong Pharm Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Huazhong Pharm Levonorgestrel API Product Portfolio
  48. 6.8.5 Huazhong Pharm Recent Developments
  49. 6.9 ASG Biochem
  50. 6.9.1 ASG Biochem Company Information
  51. 6.9.2 ASG Biochem Business Overview
  52. 6.9.3 ASG Biochem Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 ASG Biochem Levonorgestrel API Product Portfolio
  54. 6.9.5 ASG Biochem Recent Developments
7 North America by Country
  1. 7.1 North America Levonorgestrel API Sales by Country
  2. 7.1.1 North America Levonorgestrel API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Levonorgestrel API Sales by Country (2021-2026)
  4. 7.1.3 North America Levonorgestrel API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Levonorgestrel API Market Size by Country
  6. 7.2.1 North America Levonorgestrel API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Levonorgestrel API Market Size by Country (2021-2026)
  8. 7.2.3 North America Levonorgestrel API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Levonorgestrel API Sales by Country
  2. 8.1.1 Europe Levonorgestrel API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Levonorgestrel API Sales by Country (2021-2026)
  4. 8.1.3 Europe Levonorgestrel API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Levonorgestrel API Market Size by Country
  6. 8.2.1 Europe Levonorgestrel API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Levonorgestrel API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Levonorgestrel API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Levonorgestrel API Sales by Country
  2. 9.1.1 Asia-Pacific Levonorgestrel API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Levonorgestrel API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Levonorgestrel API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Levonorgestrel API Market Size by Country
  6. 9.2.1 Asia-Pacific Levonorgestrel API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Levonorgestrel API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Levonorgestrel API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Levonorgestrel API Sales by Country
  2. 10.1.1 South America Levonorgestrel API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Levonorgestrel API Sales by Country (2021-2026)
  4. 10.1.3 South America Levonorgestrel API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Levonorgestrel API Market Size by Country
  6. 10.2.1 South America Levonorgestrel API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Levonorgestrel API Market Size by Country (2021-2026)
  8. 10.2.3 South America Levonorgestrel API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Levonorgestrel API Sales by Country
  2. 11.1.1 Middle East and Africa Levonorgestrel API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Levonorgestrel API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Levonorgestrel API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Levonorgestrel API Market Size by Country
  6. 11.2.1 Middle East and Africa Levonorgestrel API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Levonorgestrel API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Levonorgestrel API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Levonorgestrel API Value Chain Analysis
  2. 12.1.1 Levonorgestrel API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Levonorgestrel API Production Mode & Process
  7. 12.2 Levonorgestrel API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Levonorgestrel API Distributors
  10. 12.2.3 Levonorgestrel API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst